// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























24782 Abstracts

Real-World Evidence (RWE) Studies Supported Hematologic Oncology United States Food and Drug Administration (US FDA) Approval: What Do They Look like?

Binglin Yue - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hematological malignancies

N/A

Short-Term Follow-up of Blinatumomab in Children with B-Cell Precursor Acute Lymphoblastic Leukemia：Study of a Single Center from China

Wenyu Yang - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Blinatumomab

Central Nervous System Relapse after CAR-T Cell Therapy in B-Cell Malignancies

Tianning Gu - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

B cell lymphomas

N/A

Phase II Clinical Trial of Camrelizumab Combined with AVD (Epirubicin, Vincristine and Dacarbazine) in the First-Line Treatment for Patients with Advanced Classical Hodgkin's Lymphoma

Shuang Zhao - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hodgkin's Lymphoma

Camrelizumab

DNA-Demethylating Agents Combined with Anti-PD-1 Inhibitors Showed Activity in Patients with Relapsed or Refractory Extranodal NK/T Cell Lymphoma Who Have Failed Immunotherapy: An Exploratory Study

Gao Yan - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

T-cell lymphoma

Asparaginase

A Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Lugui Qiu - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Peripheral T-cell lymphoma

YY-20394

A mode of perinatal factors to predict neonatal resuscitation at birth

Silu Wang - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association of Hypertensive Disorders of Pregnancy and Adverse Neonatal Outcomes among Infants 24-31 Weeks’ Gestation in China: A Multicenter Cohort Study

Jianfang Ge - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Congenital anomalies

N/A

Association of Neonatal Outcomes with Admission Hypothermia among Very Preterm Infants in Chinese Neonatal Intensive Care Units: A Retrospective Multicenter Cohort Study

Wenchao Hong - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characteristics of Home Oxygen Therapy for Preterm Infants with Bronchopulmonary Dysplasia in China: Results of a Multicenter Cohort Study

Wenxing Jiang - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Impact of Antenatal Corticosteroids on Neonatal Outcome among Very Preterm Infants Born to Mothers with Chorioamnionitis: a Multicenter Cohort Study

Qingqing Lin - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Congenital anomalies

Dexamethasone

Association between mode of delivery and neonatal outcomes among very preterm infants who received antenatal steroids: a multicenter cohort study in China

Qiaolibang Shadike - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Infant Respiratory Distress Syndrome

N/A

Association of Neonatal Outcome with Birth Weight for Gestational Age in Chinese Very Preterm Infants: A Retrospective Cohort Study

Liangliang Li - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Infant Respiratory Distress Syndrome

N/A

Impact of Maternal Diabetes Mellitus on Neonatal Outcomes among Infants <32 Weeks’ Gestation in China: A Multicenter Cohort Study

Jing Yuan - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congenital anomalies

N/A

Inorganic arsenic exposure and gut microbiota with respective folate functional pathway in children aged 4 years

Tsung-Lin Tsai - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

arsenic

Long-term Behavioral and Proliferating Neuron of Repetitive Pain in Neonatal Rat Pups

Dong Li - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Maternal and children BMI trajectory, and lipid profile regarding environmental endocrine disruptors – An 18-year birth cohort follow-up study

Shu-Li Wang - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

arsenic

Modified human milk derived peptide in the protection against experimental Necrotizing Enterocolitis.

Xiangyun Yan - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Necrotizing enterocolitis

N/A

Neonatal Outcomes of infants born at 24-31 weeks’ gestation in relation with inborn/outborn birth status in China

Lei Xia - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Perinatal Characteristics and Neonatal Outcomes of Singletons and Twins in Chinese Very Preterm Birth Infants: A Cohort Study

Min Yang - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Infant Respiratory Distress Syndrome

N/A

Copyright © 2026. QuantiNova All rights reserved